Asan Medical Center
Clinical trials sponsored by Asan Medical Center, explained in plain language.
-
Could one dose beat days of antibiotics for pancreatic surgery patients?
Disease control ENROLLING_BY_INVITATIONThis study compares two antibiotic plans for adults having pancreatic surgery. One group gets a single dose of cefazolin before surgery, while the other gets a longer regimen. The goal is to see if the single dose works just as well to prevent infections. 558 participants will be…
Phase: NA • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New drug may keep esophageal cancer at bay after chemoradiation
Disease control OngoingThis study tests whether a PD-1 inhibitor (INCMGA00012) can help prevent esophageal cancer from returning after standard chemoradiation. About 110 adults with locally advanced esophageal squamous cell carcinoma who completed chemoradiation without progression will be randomly ass…
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug aims to shrink GI cancers before surgery
Disease control OngoingThis phase 2 trial tests whether giving the immune checkpoint inhibitor IMC-001 before surgery can shrink tumors in people with resectable gastric, esophageal, or liver cancer. About 48 participants will receive two cycles of the drug, then undergo surgery. The main goal is to se…
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Diabetes drug could help heart failure patients with leaky valve
Disease control OngoingThis study tests whether enavogliflozin, a diabetes drug, can improve outcomes in people with heart failure and a leaky tricuspid valve. About 541 participants will receive either the drug or a placebo for 18 months. Researchers will track heart-related events, valve worsening, a…
Phase: PHASE3 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Should symptom-free patients get early heart valve repair? new trial investigates.
Disease control OngoingThis study looks at whether doing a heart valve repair procedure early, before symptoms appear, is better than waiting and using standard care for people with moderate mitral stenosis. The trial includes 167 participants who have no symptoms but are at risk for future heart probl…
Phase: NA • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Hepatitis b patients may be able to ditch daily pills, new trial hopes
Disease control OngoingThis study tests whether adults with chronic hepatitis B who have no liver scarring can safely stop taking antiviral drugs. The 140 participants have undetectable virus levels and negative HBeAg status. Researchers will monitor for viral relapse and liver problems over time.
Phase: PHASE4 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Robots take on heart surgery: safer for doctors?
Symptom relief OngoingThis study compares a robot-assisted heart procedure to the standard manual approach in 80 adults with stable angina who need a stent. The robot, called AVIAR, helps guide catheters and balloons. Researchers will check if the robot is as safe and effective, and if it reduces radi…
Sponsor: Asan Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New study links common blood fat to faster heart valve damage
Knowledge-focused OngoingThis study looks at 364 people with mild to moderate aortic valve narrowing (aortic stenosis) to see if those with high levels of lipoprotein(a) — a type of fat in the blood — have faster disease progression than those with low levels. Participants are observed over time using he…
Sponsor: Asan Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC